Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Blocto looks good. Seems like a good move, despite market mood.
I like the sound of that.
100% true. DMG was one of the few companies which understood that creative disruption, such as blockchain technology, would not stand as a license to steal from innocent people who wouldn't know how to close the doors to their own accounts.
Just imagine a bank manager telling you it's your fault when you find your own bank accounts empty. Such thinking is madness.
The Company, Coinbase, is a perfect example. Many people have had their Coinbase accounts drained while Coinbase tells them its not their concern.
Let's hope DMG can charge companies like Coinbase a fortune helping to make account holders whole. How? By perfecting the mapping software so that stolen property can be tracked as easily as payments, brightly showing where stolen goods are stored.
The sick notion that stealing is creative or wealth building is genuinely f'ed up. Come on DMG, show the world how blockchain can make the world a normal place again.
"Reverse Split."
209 mil shares with 168 mil float.
It would be nice if it was under 100 mil, but seems low to do reverse split.
Thoughts?
CNBC's version of the TerraPiwer article, except it names the name never mentioned: HALEU gets into mainstream print.
The bag is open and the cat is out and running. Won't be long now.
https://www.cnbc.com/2021/11/17/bill-gates-terrapower-builds-its-first-nuclear-reactor-in-a-coal-town.html?view=story%3F__source%3Dandroidappshare
PUBLISHED WED, NOV 17 20211:29 PM ESTUPDATED WED, NOV 17 2021
Bill Gates’ TerraPower has chosen Kemmerer, Wyoming, a frontier-era coal town, as the site where the company will build its first demonstration nuclear power plant.
The plant will cost about $4 billion, half coming from TerraPower and half coming from the United States government, the company said.
Rocky Mountain Power — a division of PacifiCorp, which is owned by Berkshire Hathaway Energy — will operate the plant, which will play a role in the power company’s decarbonization strategy.
TerraPower, a start-up co-founded by Bill Gates to revolutionize designs for nuclear reactors, has chosen Kemmerer, Wyoming, as the preferred location for its first demonstration reactor. It aims to build the plant in the frontier-era coal town by 2028.
Construction of the plant will be a job bonanza for Kemmerer, with 2,000 workers at its peak, said TerraPower CEO Chris Levesque in a video call with reporters Tuesday.
It will also provide new clean-energy jobs to a region dominated by the coal and gas industry. Today, a local power plant, a coal mine and a natural gas processing plant combined provide more than 400 jobs — a sizeable number for a region that has only around 3,000 residents.
“New industry coming to any community is generally good news,” Kemmerer Mayor William Thek told CNBC. “You have to understand, most of our nearby towns are 50 miles or more from Kemmerer. Despite that, workers travel those distances every day for work in our area.”
For TerraPower, picking a location was a matter of geological and technical factors, such as seismic and soil conditions, and community support, said Levesque.
Once built, the plant will provide a baseload of 345 megawatts, with the potential to expand its capacity to 500 megawatts.
For reference, 1 gigawatt, or 1,000 megawatts, of energy will power a midsize city, and a small town can operate on about 1 megawatt, according to a rule of thumb Microsoft co-founder Gates provided in his recent book, “How to Avoid a Climate Disaster.” The United States uses 1,000 gigawatts and the world needs 5,000 gigawatts, he wrote.
The future of nuclear power
It will cost about $4 billion to build the plant, with half of that money coming from TerraPower and the other half from the U.S. Department of Energy’s Advanced Reactor Demonstration Program.
“It’s a very serious government grant. This was necessary, I should mention, because the U.S. government and the U.S. nuclear industry was falling behind,” said Levesque.
“China and Russia are continuing to build new plants with advanced technologies like ours, and they seek to export those plants to many other countries around the world,” Levesque said. “So the U.S. government was concerned that the U.S. hasn’t been moving forward in this way.”
Once built, the plant should provide power for 60 years, Levesque said.
How TerraPower’s reactors are different
The Kemmerer plant will be the first to use an advanced nuclear design called Natrium, developed by TerraPower with GE-Hitachi.
Natrium plants use liquid sodium as a cooling agent instead of water. Sodium has a higher boiling point and can absorb more heat than water, which means high pressure does not build up inside the reactor, reducing the risk of an explosion.
Also, Natrium plants do not require an outside energy source to operate their cooling systems, which can be a vulnerability in the case of an emergency shutdown. This contributed to the 2011 disaster at the Fukushima Daiichi nuclear plant in Japan, when a tsunami shut down the diesel generators running its backup cooling system, contributing to a meltdown and release of radioactive material.
Natrium plants can also store heat in tanks of molten salt, conserving the energy for later use like a battery and enabling the plant to bump its capacity up from 345 to 500 megawatts for five hours.
The plants are also smaller than conventional nuclear power plants, which should make them faster and cheaper to build than conventional power plants. TerraPower aims to get the cost of its plants down to $1 billion, a quarter of the budget for the first one in Kemmerer.
“One important thing to realize is the first plant always costs more,” said Levesque.
Finally, Natrium plants produce less waste, a problematic and dangerous byproduct of nuclear fission.
‘Times are changing’
The Kemmerer plant still faces a couple of hurdles, including federal permitting.
“There’s a comprehensive licensing process overseen by the Nuclear Regulatory Commission that, frankly, is expensive,” Levesque said. “There are many, many reviews.”
Also, the fuel that the Natrium plant uses is called high-assay low-enriched uranium, or HALEU, which is not yet available at commercial scale.
Remember a few weeks back when I posted a CNBC Youtube video of a regular person who bought crypto, kept it in a Coinbase account, built it up to over $1 million and then signed on to find his account hacked and drained, while Coinbase told him it wasn't their problem. I called Coinbase a piece of shit
Turns out I was right. Here's a leaked conversation about pieces of shit texting to each other:
Could be a difficult day for miners as MARA stock got slammed after SEC hit them with a subpoena.
https://www.investors.com/news/marathon-digital-mara-stock-buy-now/?src=A00220
Bad luck to happen on the day before another great Hive earnings report. Especially liked this line: "HIVE ended the September quarter holding 1,116 Bitcoin (“BTC”) worth $48.4 Million and 25,154 Ether (“ETH”) worth $74.7 Million."
Report also said: "Mined 656 Bitcoin and over 8,688 Ethereum during the three-month period."
So, they must have a disciplined manner of hodling some and selling some or else they would have more. It's good to not have debt.
In the email release it didn't show cash level, but this is a remarkable margin number: "Gross mining margin during the period was $45.0 million, or 86% of income from digital currency mining, compared to $9.2 million, or 71% of income from digital currency mining, in the same period in the prior year."
So, who is now managing Akanda?
Quote from announcement: "As a result, Halo owns approximately 68.3% of the issued and outstanding Akanda Shares."
I searched share total and this number is from Yahoo:
Shares Outstanding : 21.79M.
Is this right?
I found another site which had 1.9 billion shares, but I assume this was the pre-reverse split number where our shares were decimated.
But, truth is: 21.79mil is not a bad number.
This was just out on Bloomberg:
https://www.bloomberg.com/press-releases/2021-11-16/halo-collective-reports-third-quarter-2021-financial-results
Halo Collective Reports Third Quarter 2021 Financial Results Canada NewsWire TORONTO, Nov. 15, 2021 /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ -- Halo reports 28% year-over-year revenue growth -- Conference call to be held November 16, 2021, at 4:15 p.m. ET All figures in USD unless stated otherwise TORONTO, Nov. 15, 2021 /CNW/ - Halo Collective Inc. ("Halo" or the "Company") (NEO: HALO) (OTCQB: HCANF) (Germany: A9KN) today announced its financial and operational results for three months ended September 30, 2021 ("Q3 2021"). Third Quarter 2021 Financial Highlights: * Revenue of $8.7 million, up $1.9 million, or 28.0%, compared to $6.8 million in Q3 2020, including the sale of over 9.2 million grams of cannabis products principally to dispensaries in Oregon and California, a 620% year-over-year increase. * Organic revenue growth was 9% ^1 despite a significant downturn in both the California and Oregon markets. * Adjusted gross profit ^1 was $2.3 million, or 26.5% gross margin, compared to $2.4 million, or 35.7% gross margin, in Q3 2020. * Adjusted EBITDA ^1 of $(4.5) million compared to $0.5 million in Q3 2020 and $(4.4) million from Q2 2021. "The difficult conditions in our California and Oregon markets are having a short-term impact on our financial results but not on our determination to make the Company profitable and boost shareholder value," said CEO Kiran Sidhu. "We are actively executing a four-pronged strategy consisting of growing our wholesale business in California and Oregon, launching California retail in Los Angeles, streamlining costs and monetizing equity positions in Akanda, Triangle Canna and HaloTek. Even with the strong headwinds in both California and Oregon, we believe that we have a path to profitability in 2022." On November 4, 2021, Halo completed its previously announced transaction with Akanda Corp. ("Akanda") as part of its international re-organization efforts. This significantly reduces Halo's overheads provides Halo with a $6.6 million secured convertible debenture and an approximate 68% equity position in Akanda. On November 10, 2021, the Company announced the planned $75 million Reg A+ financing (the "Triangle Financing") by Triangle Canna Corp. ("Triangle Canna"). Halo maintains a 44% equity stake in Triangle Canna, which is being valued at $165 million prior to the completion of Triangle Financing. The Triangle Financing has been qualified by the U.S Securities Exchange Commission and is expected to launch prior to December 2021. There can be no certainty as to the timing or success of the Triangle Financing. The Company also expects Elegance Brands, Inc. ("Elegance") to be listed on a major North American exchange by March 2022, which would provide additional liquidity to monetize Halo's shareholding position in Elegance. "We believe Halo is currently trading at a significant discount, by spinning off non-core assets, shareholders are expected to benefit from this unlocked value." Mr. Sidhu continued, "The Oregon and California markets have seen a significant decline in gross sales over the last two quarters, mainly attributed to competition for consumer discretionary funds from other industries as the effects of COVID restrictions ease and oversupply of cannabis putting pressure on pricing which has declined significantly. According to BDSA, California was down 18% from April through September, while Oregon saw a smaller decline of 15%. Halo, on the other hand, bucked the industry trend seeing an increase in gross sales of 59% in California and a small decrease of 7% in Oregon over the same period. Our share gains in both states position us well to be one of the leaders in a consolidated market as marginal and undercapitalized competitors fail and market conditions improve in 2022." "Operationally, we are pulling multiple levers to drive growth and improved profitability within our core markets. We are revamping and intend to launch over 50 new products over the next six months, including pre-rolls, gummies, vapes, beverages, and Hushrooms ^TM , a non-cannabis functional mushroom product. This includes leveraging the Simply Sweet platform to expand and upgrade all of our edibles offerings across multiple high-demand emerging product categories such as vegan, plant-based, natural, and low sugar. In beverages, we are developing a microdosed concept and plan to leverage our relationship with Elegance for mainstream distribution in stores of CBD and functional mushroom drinks. Our balance sheet remains strong." Philip Van Den Berg, CFO, continued, "We are tracking toward slightly higher sequential revenue growth in the fourth quarter and withdraw our guidance for the year ending on December 31, 2021. We are using this market downturn as an opportunity to accelerate our plan to reduce costs significantly. We have identified approximately $6.7 million of anticipated quarterly cost savings ($26.8 million annually) that we are implementing, including a reduction in corporate and production overheads, the separation of Akanda, and the reduction of external professional fees. Additionally, the working capital should release as we turn inventory more quickly as East Evans Creek delivers cannabis to the Oregon sales force that has been harvested and fully paid up except for trimming, distribution, and commissions. We could achieve profitability in the first half of 2022 and expect to reduce our losses in the fourth quarter of 2021." California Market Update While the largest legal market in the U.S., California's market conditions have recently softened and experienced a significant decline in gross legal sales from calendar Q2 to Q3 of 2021. The decline has been attributed to competition for consumer discretionary spending from other industries as the effects of COVID restrictions ease as well as a large glut in the supply chain of cannabis. California retail sales were down 18% from April 1 to September 30 in 2021, resulting from price reductions and quantity concessions. ^2 However, Halo believes that conditions in the state will improve within a year based on similar downturns in Oregon, Washington, and Colorado. The Company expects there will be attrition in flower supply in the legal California market over the next 12 months that could lead to many existing farms exiting the market, not unlike Oregon, where some of the marginal suppliers have closed. In 2022, new California state regulations prevent stacked cultivation licenses on contiguous property starting in January, meaning new applicants may only obtain four cultivation licenses per parcel totaling 40,000 square feet. ^3 In addition, the state is requiring all provisional licenses to convert to annual licenses by the middle of 2022, which may reduce the supply of licenses, and the California Environmental Quality Act( "CEQA") review is expected to be a critical material factor in conversion which will be difficult for many operators to obtain. Currently, there are 8,466 Cultivation Licenses in California, of which 2,401 of them are "Annual." ^4 These licenses will be grandfathered into the prior state program, which did not set canopy limits per parcel. Starting in July 2022, the 6,065 temporary "Provisional" licenses must have their CEQA plans approved by the local government and California Department of Cannabis Control to convert to annual and be grandfathered into their legacy canopy footprint under prior state regulations. Any extension of provisional licensing will be challenging to come by. California Retail Rollout Update Halo's Los Angeles retail rollout is an important step in its vertical integration "Seed to Sale" strategy in the state. The Westwood store is expected to open in December 2021, followed by the Hollywood store in January 2022 and the North Hollywood store by June of 2022. Opening under the Company's new retail brand Budega™, these stores are expected to increase distribution of Hush, FlowerShop* and our own Budega™ branded products in California, and after an approximate six-month ramp up period, should contribute net revenue and gross profit. Third Quarter 2021 Financial Results Revenue Revenues in Q3 2021 were $8.7 million compared to $6.8 million in Q3 2020, a 28.0% increase. Total sales were 9,241,224 grams (Q3 2020: 1,283,087 grams), a 620% increase. Organic revenue growth was 9%. ^1 Revenue growth was mixed across the Company's subsidiaries which include ANM Inc. ("ANM"), the owner of the Company's facility in Oregon; Mendo Distribution and Transportation LLC ("MDT"), the owner of the facility in Ukiah; Coastal Harvest LLC ("Coastal Harvest"), Halo's extraction facility in California; Halo Winberry Holdings, LLC ("Halo Winberry"), which operates a one-acre grow outside of Eugene, Oregon; and Halo Kushbar Retail Inc., the operator of three retail cannabis stores in the province of Alberta. ANM reported revenues of $3.7 million, a 6.0% decrease over Q3 2020. MDT reported revenues of $3.1 million, a 41.5% increase over Q3 2020. Coastal Harvest reported revenues of $0.7 million, a 1.8% decrease compared to Q3 2020. Halo Winberry and Halo Kushbar Retail reported revenues of $3.1 million and $0.5 million, respectively. Halo Winberry's and Halo Kushbar Retail's results were not included in the three months ended September 30, 2020. Gross Profit The Company reported a gross profit of $1.6 million (Q3 2020: gross profit of $1.6 million), with a reported gross margin of 18.8% (Q3 2020: 67.1%). Adjusted for the loss on biological assets, gross profit was $2.3 million (Q3 2020: $2.5 million), with an adjusted gross margin of 26.5% (Q3 2020: 35.7%). Liquidity and Cash Balance As of September 30, 2021, Halo had available cash in the amount of $8.0 million and approximately $523,000 in restricted cash. During the quarter, a total of 806,651 common shares in the capital of Halo ("Common Shares") were issued in connection to the at-the-market public offering for gross proceeds of $4.1 million (C$5.1 million). ANM In Q3 2021, ANM, the owner of the Company's facility in Oregon, sold 1,725,936 grams of shatter, cartridge oil, live resin, tinctures and gummies, flower, and pre-rolls (Q3 2020: 895,840 grams), a 92.7% increase. Sales of oil and extracts were 311,066 grams (Q3 2020: 346,236 grams), a 10.2% decrease. The wholesale price of oils, extracts and edibles increased by 4.6% to $7.14 per gram (Q3 2020: $7.48 per gram). Flower sales in Q3 2021 were 730,579 grams (Q3 2020: 224,687 grams), a 225.2% increase. The wholesale price of flower decreased by 24.5% to $0.85 per gram (Q3 2020: $1.13 per gram). Pre-roll sales were 605,757 grams (Q3 2020: 178,572 grams), a 239.2% increase. The wholesale price of pre-rolls increased by 49.7% to $0.77 per gram (Q3 2020: $1.54 per gram). MDT In Q3 2021, MDT, the owner of the facility in Ukiah, sold 5,203,541 grams of distillate, live resin, gummies, and pre-rolls (Q3 2020: 180,304). Halo Winberry Halo Winberry sold 2,083,180 grams of oil and extracts, shatter, live resin, edibles, flower, pre-rolls, and trim. Prices ranged from $9.69 per gram for oils and extracts, $4.44 for edibles, $4.22 for pre-rolls, to $0.23 per gram for trim. Simply Sweet Gummy Acquisition Completed Halo also today announced that, further to its press release dated November 4, 2021, the Company has completed the acquisition of all of the issued and outstanding shares of Simply Sweet Gummy Ltd. ("Simply Sweet"), a health-conscious, low-sugar cannabis infused alternative confectionery company based in Vancouver, British Columbia. In consideration for all of the issued and outstanding shares of Simply Sweet, which holds assets and formulations (including $1 million in cash), the Company issued 2,700,000 Common Shares to the previous shareholder of Simply Sweet. The Company has also issued 202,500 Common Shares to an arm's-length finder. Earnings Conference Call Halo will host a live webinar at 4:15 p.m. Eastern Time on Tuesday, November 16, 2021, to discuss its results. To access the webinar, visit http://www.directeventreg.com/registration/event/4972706 . The webinar will also be available on a telephonic replay after the event until November 23, 2021. To access the replay, dial 1-(800) 585-8367 (toll free) or (416) 621-4642 (international) and enter conference ID: 4972706. 2021 Guidance As described previously, the Company is withdrawing 2021 financial guidance primarily due to: * Competition for consumer discretionary funds from other industries as the effects of COVID restrictions ease * Oversupply of cannabis in both California and Oregon * Leading to both decreased retail prices (deflation) and unit quantities purchased The Company plans to give 2022 guidance on or before releasing annual financial results on April 15, 2022. Additional Information Complete results are reported in the Company's consolidated financial statements for the three months ended September 30, 2021, and associated management's discussion and analysis (the "Q3 2021 MD&A"). About Halo Collective Inc. Halo is a leading, vertically integrated cannabis company that cultivates, extracts, manufactures, and distributes quality cannabis flower, oils, and concentrates and has sold approximately eleven million grams of oils and concentrates since inception. The Company continues to expand its business and scale efficiently, partnering with trustworthy leaders in the industry who value Halo's operational expertise in bringing top-tier products to market. Halo currently operates in the United States in Oregon and California. The Company sells cannabis products principally to dispensaries in the U.S. under its brands Hush, Mojave, and Exhale, and under license agreements with Papa's Herb ^® , DNA Genetics, Terphogz, and FlowerShop*, a cannabis lifestyle and conceptual wellness brand that includes G-Eazy as a partner and key member. As part of continued expansion and vertical integration in the U.S., Halo boasts several grow operations throughout Oregon and two planned in California. In Oregon, the Company has a combined 11 acres of owned and contracted outdoor and green house cultivation, including East Evans Creek, a six-acre grow site in Jackson County with four licenses owned and operated by Halo and two third-party licenses under contract to sell all of their product to Halo; Winberry Farms, a one-acre grow site located 30 miles outside of Eugene in Lane County with a license owned and operated by Halo; and William's Wonder Farms, a three-acre grow site in Applegate Valley, under contract to sell all of its product to Halo pending the closing of Halo's acquisition of its licenses and business assets. Halo has recently acquired Food Concepts LLC, a master tenant of a 55,000 square foot indoor cannabis cultivation, processing, and wholesaling facility in Portland, Oregon operated by the Pistil Point entities. In California, the Company is building out Ukiah Ventures, a planned 30,000 square foot indoor cannabis grow and processing facility, which aims to include up to an additional five acres of industrial land to expand the site. Recently, Halo partnered with Green Matter in California to purchase the Farm in Lake County, developing up to 63 acres of cultivation, comprising one of the largest licensed single site grows in California. Halo also plans to expand its operations in California by opening three dispensaries under the Budega™ brand in North Hollywood, Hollywood, and Westwood. In Canada, Halo acquired three KushBar retail cannabis stores located in Alberta as a first in its planned entry into the Canadian market, leveraging its Oregon and California brands. With the KushBar retail stores as a foundation, the Company plans to expand its foothold in Canada. Halo has also acquired a range of software development assets, including CannPOS, Cannalift, and, more recently, CannaFeels. In addition, Halo owns the discrete sublingual dosing technology, Accudab. The Company intends to spin-off these assets and its intellectual property and patent applications into its subsidiary Halo Tek Inc. and expects to complete a distribution to shareholders on a record date to be determined by Halo. Halo recently completed the sale of certain of its non-U.S. operations to Akanda Corp., whose mission is to provide high-quality and ethically sourced medical cannabis products to patients worldwide. As an independent company, Akanda is seeking to deliver on this promise while driving positive change in wellness, empowering individuals in Lesotho, and uplifting the quality of the lives of employees and the local communities where it operates, all while limiting its carbon footprint. Akanda combines the scaled production capabilities of Bophelo Bioscience & Wellness Pty. Ltd., a Lesotho-based cultivation and processing campus located in the world's first Special Economic Zone (SEZ) containing a cannabis cultivation operation, with distribution and route-to-market efficiency of CanMart Ltd., UK-based fully approved pharmaceutical importer, and distributor that supplies pharmacies and clinics within the UK With a potential maximum licensed canopy area of 200 hectares (495 acres), Bophelo has scalability that is arguably unmatched in the world today. Following the sale, Halo is Akanda's largest shareholder. For further information regarding Halo, see Halo's disclosure documents on SEDAR at www.sedar.com.
IDT up $5.67 today. Somebody should say something.
Is winter over? Has the Ice King been fought back?
November 10 2021 - 04:15PM
GlobeNewswire Inc.
Results from the third quarter show strong potential for future growth, said Predictive Oncology (Nasdaq: POAI) today, announcing financial results for the quarter ended September 30, 2021. All three of Predictive Oncology’s reportable segments recognized revenue for the quarter, and the loss per common share was reduced to $0.08, compared to $0.46 for the same period in 2020.
The knowledge-driven company, which is applying artificial intelligence (“AI”) to personalized medicine and drug discovery, also provided an update on its business activities. Highlights from the quarter include:
Net increase in cash and equivalents amounting to $41 million in the nine months ended September 30, 2021, compared to $2.3 million for the same period in 2020.
No outstanding debt.
Subsidiary Helomics used data from 100,000 Genomes Project to better predict ovarian cancer outcomes.
Introduced Raymond F. Vennare, accomplished senior executive, board director and biotechnology entrepreneur as newest member of the Board of Directors.
“We are looking forward to the outcome of our Discovery 21 program, which we believe will realize our goal of providing pharmaceutical companies with a quicker, less costly means to drug discovery,” said J. Melville Engle, the Company’s Chairman and Chief Executive Officer. “We expect our CoRE™ platform to disrupt pharma, with our AI technology leading to new discoveries that will drive steady growth in our business segments.”
Q3 2021 Financial results
The Company recorded revenue of $313,663 for the quarter, compared to $480,757 for the same quarter in 2020. The difference was largely due to fewer STREAMWAY System units being sold in its Skyline Medical business, the segment that typically generates most of the Company’s current revenue.
G&A expenses decreased $165,176 for the three months ended September 30, 2021, compared to 2020, and $856,719 for the nine months ended September 30, 2021, compared to 2020.
The gross profit margin was approximately 65% and 63% in the three and nine months ended September 30, 2021, respectively, roughly equivalent to the prior year.
Operations expense increased by $80,169 to $648,935 in the three months ended September 30, 2021 compared to 2020, primarily due to higher staff and AI computing costs. These were partially offset by lower consulting expenses.
Net cash used in operating activities was $8,464,821 and $9,953,785 for the nine months ended September 30, 2021 and September 30, 2020, respectively. Cash used in operating activities decreased in the 2021 period primarily because of the decrease in cash used for working capital and the lower operating costs related to the Helomics and Skyline business.
The Company’s quarterly sales and marketing expenses increased by $51,355 for the quarter to $172,869 compared to the same period in 2020. This was a direct result of increased advertising and promotion including website development, market research and trade shows, offset by lower commissions expenditures in the Skyline Medical business.
About Predictive Oncology Inc.
Predictive Oncology (NASDAQ: POAI) operates through three segments (Skyline, Helomics, and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech.
Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. TumorGenesis Inc. specializes in media that help cancer cells grow and retain their DNA/RNA and proteomic signatures, providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. Skyline Medical markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. Soluble Biotech is a provider of soluble and stable formulations for proteins including vaccines, antibodies, large and small proteins and protein complexes.
Forward-Looking Statements:
Certain matters discussed in this release contain forward-looking statements. These forward-looking statements reflect our current expectations and projections about future events and are subject to substantial risks, uncertainties and assumptions about our operations and the investments we make. All statements, other than statements of historical facts, included in this press release regarding our strategy, future operations, future financial position, future revenue and financial performance, projected costs, prospects, plans and objectives of management are forward-looking statements. The words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “would,” “target” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Our actual future performance may materially differ from that contemplated by the forward-looking statements as a result of a variety of factors including, among other things, factors discussed under the heading “Risk Factors” in our filings with the SEC. Except as expressly required by law, the Company disclaims any intent or obligation to update these forward-looking statements.
PREDICTIVE ONCOLOGY INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
September 30,
2021 December 31,
2020
(unaudited) (audited)
ASSETS
Current Assets:
Cash and cash equivalents $ 41,771,515 $ 678,332
Accounts Receivable 275,193 256,878
Inventories 397,976 289,535
Prepaid Expense and Other Assets 595,224 289,490
Total Current Assets 43,039,908 1,514,235
Fixed Assets, net 3,810,640 3,822,700
Intangibles, net 3,199,047 3,398,101
Lease Right-of-Use Assets 961,419 1,395,351
Other Long-Term Assets 179,096 116,257
Goodwill - 2,813,792
Total Assets $ 51,190,110 $ 13,060,436
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts Payable $ 1,029,545 $ 1,372,070
Notes Payable – Net of Discounts of $0 and $244,830 - 4,431,925
Accrued Expenses and other liabilities 940,892 2,588,047
Derivative Liability 225,498 294,382
Deferred Revenue 152,546 53,028
Lease Liability 637,352 597,469
Total Current Liabilities 2,985,833 9,336,921
Lease Liability – Net of current portion 388,473 845,129
Other long-term liabilities 30,898 235,705
Total Liabilities 3,405,204 10,417,755
Stockholders’ Equity:
Preferred Stock, 20,000,000 authorized inclusive of designated below
Series B Convertible Preferred Stock, $.01 par value, 2,300,000 shares authorized, 79,246 and 79,246 shares outstanding 792 792
Common Stock, $.01 par value, 200,000,000 and 100,000,000 shares authorized, 65,457,484 and 19,804,787 outstanding 654,575 198,048
Additional paid-in capital 167,413,309 110,826,949
Accumulated Deficit (120,283,770 ) (108,383,108 )
Total Stockholders’ Equity 47,784,906 2,642,681
Total Liabilities and Stockholders’ Equity $ 51,190,110 $ 13,060,436
PREDICTIVE ONCOLOGY INC.
CONDENSED CONSOLIDATED STATEMENTS OF NET LOSS
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2021 2020 2021 2020
Revenue $ 313,663 $ 480,757 $ 944,187 $ 958,484
Cost of goods sold 110,165 175,206 350,800 353,124
Gross profit 203,498 305,551 593,387 605,360
General and administrative expense 2,061,458 2,226,634 7,410,208 8,266,927
Operations expense 648,935 568,766 1,791,543 1,638,635
Sales and marketing expense 172,869 121,514 447,298 518,938
Loss on goodwill impairment 2,813,792 2,997,000 2,813,792 2,997,000
Total operating loss (5,493,556 ) (5,608,363 ) (11,869,454 ) (12,816,140 )
Other income 58,830 44,926 144,122 97,894
Other expense (7,413 ) (2,147,057 ) (244,214 ) (3,993,969 )
Gain (loss) on derivative instruments 4,122 1,402,768 68,884 1,007,794
Gain on notes receivables associated with asset purchase - - - 1,290,000
Net loss $ (5,438,017 ) $ (6,307,726 ) $ (11,900,662 ) $ (14,414,421 )
Deemed dividend - 554,287 - 554,287
Net loss attributable to common shareholders per common shares-basic and diluted $ (5,438,017 ) $ (6,862,013 ) $ (11,900,662 ) $ (14,968,708 )
Loss per common share basic and diluted $ (0.08 ) $ (0.46 ) $ (0.23 ) $ (1.51 )
Weighted average shared used in computation - basic 65,406,312 15,026,789 51,272,960 9,935,738
This is a test. To whom it may concern: I can read but have no private reply option. email?
Regarding 45 minute conference call: again, outstanding, right to this last question:
And they continue protecting their patents: awesome. They know this is a cut-throat crowd, pirates willing to steal their LTBRs truth and wealth.
https://finance.yahoo.com/news/lightbridge-receives-notice-allowance-key-130000775.html
Huge volume today. Perhaps Hive will mimic on the Nasdaq their Canadian heights when they were the most liquid stock on the Toronto exchange:
https://ca.finance.yahoo.com/news/hive-blockchain-most-liquid-tsx-222000528.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAFyZou1rMPDFbCK5eytuRF8rl52opRe2LzaZguyqaADhg71R-009YKMWHMGGt8SIIL8k58LmI2GVykG_9bNxMorubT3av0bylgAkeXSUOG09ygGW8s88m1_1-MwA5LZT-10ON6cYdiz_TcCQ22GwdT6n34PgPyLQLP9MHhNNHcd_
2021 volume:
https://finance.yahoo.com/quote/HIVE/history?p=HIVE
No worries, just the professional traders using our heads as the ball in their racquetball games.
One dollar is one tenth of ten dollars: ten bagger.
Listening to conference call. Outstanding: CEP Richard Carter seems to be the real deal:
https://seekingalpha.com/article/4466966-bragg-gaming-group-inc-brag-ceo-richard-carter-on-q3-2021-results-earnings-call-transcript
One example of this is this paragraph, at 3 min 56 seconds. And don't be confused that the dumb-bot writes out numbers, so the text reads like this:
03:56: We have raised our twenty twenty one full year revenue guidance to a range of fifty five million EUR to fifty six million EUR and our adjusted EBITDA outlook to between six point six million EUR and six point eight million EUR. While also raising our twenty twenty two revenue outlook to a range of fifty nine million EUR to sixty one million EUR on our twenty twenty two adjusted EBITDA outlook to between six million EUR and seven million EUR. These results and our forward expectations represent strong performance and underlying growth in our non-German market.
Listening to conference call. Outstanding: CEP Richard Carter seems to be the real deal:
https://seekingalpha.com/article/4466966-bragg-gaming-group-inc-brag-ceo-richard-carter-on-q3-2021-results-earnings-call-transcript
One example of this is this paragraph, at 3 min 56 seconds. And don't be confused that the dumb-bot writes out numbers, so the text reads like this:
03:56: We have raised our twenty twenty one full year revenue guidance to a range of fifty five million EUR to fifty six million EUR and our adjusted EBITDA outlook to between six point six million EUR and six point eight million EUR. While also raising our twenty twenty two revenue outlook to a range of fifty nine million EUR to sixty one million EUR on our twenty twenty two adjusted EBITDA outlook to between six million EUR and seven million EUR. These results and our forward expectations represent strong performance and underlying growth in our non-German market.
Your statement has a nice ring to it.
Ameritrade doesn't even have the info this board has. At 10:15AM, Benzinga reports a Reuters report of this minor update: "... expanded bitcoin production of 1 added exahash/second for summer 2022."
No mention of 16mil shares at $6. Not sure why this caused a halt.
And sure, the market always freaks first, then sorts it out. This keeps us all crazy.
On Feb 19, 2021, HIVE hit $5.75 and closed at $5.37.
We're within spitting distance. Unfortunately, headwinds can make spitting hard to get past one's shoes.
All time high in the A.M.?
4th quarter earnings will likely be adding to the run of blowout quarters.
Fair enough. It's a pleasure "talking" with someone for whom "agree to disagree" even exists. That alone gets us most of the way toward once again having a reasonably functional society where well-intentioned people can work together to solve real problems.
Such as the price of gas going up and OPEC voting not to bring prices down:
https://finance.yahoo.com/news/biden-weighs-response-opec-rebuff-104656928.html
Go LTBR, capable of bringing a more sane energy into the world.
Here we will disagree. Greenwald co-founded The Intercept and resigned in 2020 because his writing had been changed prior to publication. As a supposed forum for "independent journalists," he called foul and quit. My understanding is that the Intercept, founded as a beacon of free speech, also succumbed to what became known as trump derangement syndrome. Clearly, the larger press lost its way, but The Intercept was supposed to allow independence. Greenwald had written a story critical of some of the dems bad behaviors. As a consequence, he got slapped--and edited--by colleagues and the Intercept's funder. The Intercept is subsidized journalism (it was seen as a charity), but it had promised each journalist true independence. Greenwald's piece was not allowed and so he quit. He wasn't a trump supporter, just wrote about the dems messing with reality and this led to The Intercept breaching the sacrosanct rule of independent journalism. Greenwald resigned rather than rewrite his piece and now writes at Substack where he's on his own.
I don't agree with everything he says or writes, but he was willing to call BS on both the dems--when they deserved it--and The Intercept for breaking their own free speech rule.
We are once again learning the lesson that free speech is not as simple as it seems. But it's still the right thing to do. Just my 2cents.
From today's press release. Not sure, but can companies, or countries, pay to experiment with LTBR fuel? Or must all such research be done in laboratory settings?
If a company does research using LTBR fuels, what safeguards are there they won't steal/reverse engineer the tech in order to design a few version?
What are the rules? It seems to me, LTBR is at risk of such shenanigan's. Seems like that's what happened with Framatome.
Thoughts?
Awesome. The Intercept is okay, but I think they messed up when they attempted to cancel founder Glenn Greenwald, not allowing him to write independently. Still, Ryan Grimm from Rising, I think, still writes for Intercept.
Rising also did a few about this hilarious or sad story: amateur stock traders who follow congress in order to trade like they do. Apparently, Nancy Pelosi could be a professional, given her uncanny ability to buy or sell at exactly the right moment:
https://housestockwatcher.com/summary_by_rep
Bill does have his moments. He walks the razors edge and I respect him for that.
Fast and furious, the truth is picking up steam. Watch quickly, the door to honesty won't be open long.
QUESTION: Why does Joe Manchin support nuclear energy?
A. Because he believes in the nuclear future.
B. Because he's a closet environmentalist who secretly wants to help America regain its place of trust in world politics.
C. Because he fears his family will lose their family fortunes built from coal mining.
D. All of the above.
I think there's only one right answer. What do you think?
Times up. Watch this video for the answer brought to you by real journalists, ones who actually investigate what is true, unlike the legacy journalists who have collectively decided to tell the American public how they are supposed to think; truth be damned..
Boom, boom Boominator, this congressional conversation happened yesterday.
Thanks for finding and posting this terrific article. Politically savvy, aware of nuclear's reputation and it even mentions the irony of every western nation shutting down nuke plants, not opening them as China seems to be doing. But there is so much left out of even this article.
Who maintains the big timetable which articles like this follow? I've never heard of these big plan before, but obviously, these plans have been going on and carried out for many years, even decades.
And yet again, the article includes the predictable NOT mentioning anything about HALEU or any of the new fuels. Meanwhile, LTBR continues to rack up patents. For what purpose?
Question: are these plants being built for new fuels or old fuels? If the latter, why?
Why not build using the safe fuels, the fuels which can't repeat 3 Mile Island?
China is betting the world on this decision. They are playing a big game and the world should, perhaps, tell them no loans unless they use HALEU.
Why would they not start using new fuels, at least in some plants. If it works as research seems to show, then use it for all. Use it for safety and environmental reasons.
Who is getting rich by not starting with HALEU fuels? It should be a scandal. Even this article speaks of the length of time nuke waste needs to sit perfectly for 100k years, or some such sci madness. That's bad design already.
But sanity will not be allowed. Too much money at stake. The old guard, and the new Chinese who will become the new old guard, will likely start with the old fuels. This new old guard will suck as many dollars as they can out of it before the new fuels are brought in to save the environmental day.
Instead of doing the environmentally right and smart thing from the beginning, they don't seem so inclined.
So, LTBR will be left hanging on the hook once again.Seems funny, LTBR will be the industry's ace in the hole. And they'll all look like heros while stretching out the time it takes to make the world a safer place.
And who can guarantee no accidents will happen while they wait to do the right and smart nuke thing?
At 19 million shares, lets hope we all live long enough to see the big pimple popping squeeze. But my inner cynic tells me the old nuclear guard are going to design around LTBRs patents, leaving enough crumbs to keep the lawyers at bay. In other words, business as usual.
Ameritrade news: Benzinga: "Esports Entertainment Group, Inc. (NASDAQ:GMBL) gained 29% to settle at $7.57. Roth Capital initiated coverage on Esports Entertainment with a Buy rating and announced a price target of $22."
and this is interesting. It's a strong belief in the future of this company. Pay $10 for $17.50 (or more) later. IMHO: this company believes the bottom is in.
November 3, 2021 04:02 PM ET (BZ Newswire) -- News
Esports Entertainment Group, Inc. (NASDAQ:GMBL) (NASDAQ:GMBLW) (or the "Company") today announced it has commenced an underwritten registered public offering of its 10.0% Series A Cumulative Redeemable Convertible Preferred Stock, par value $0.001 per shares (the "Series A Preferred Stock"), at a price of $10.00 per share. Each share of Series A Preferred Stock will be convertible into shares of the Company's common stock, at a conversion price of $17.50 per common share, at any time at the option of the holder. In connection with this offering, the Company expects to grant the underwriters a 45-day option to purchase an additional 225,000 shares of Series A Preferred Stock at the public offering price, less underwriting discounts and commissions.
Currently, no market exists for the Series A Preferred Stock. The Company has filed an application to list the Series A Preferred Stock on the NASDAQ Capital Market under the symbol "GMBLP." If the application is approved, trading of the Series A Preferred Stock is expected to begin within three business days after the initial issuance of the Series A Preferred Stock.
Maxim Group LLC and Joseph Gunnar & Co., LLC are acting as book-running managers for the offering.
This offering is being made pursuant to an effective shelf registration statement on Form S-3 (No. 333-252370) that the Company previously filed with the Securities and Exchange Commission (the "SEC"), which became effective on February 5, 2021. The offering will be made only by means of the written prospectus supplement and the accompanying prospectus that form a part of the registration statement. The preliminary prospectus supplement and the accompanying prospectus relating to the offering will be filed with the SEC and, when filed, will be available on the SEC's website located at http://www.sec.gov. Copies of the preliminary prospectus supplement and the accompanying prospectus, when available, may also be obtained by contacting Maxim Group LLC, 300 Park Avenue, 16th Floor, New York, NY 10022, or by telephone at (212) 895-3745.
This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.
Copyright © 2021 Benzinga
FDMSF's last real news was Oct 14, only a few weeks ago:
Vancouver, British Columbia –October 14, 2021 -- InvestorsHub NewsWire -- Fandom Sports Media Corp. (CSE: FDM) (OTCQB: FDMSF) (FRANKFURT: TQ43) ("Fandom Sports" or the "Company"), is pleased to announce that it has entered into a technology partnership with cryptocurrency platform Polygon, with the aim of supporting efficient and scalable NFT minting on Fandom Sports' www.fandomart.com ("FANDOMART") NFT marketplace.
It's unlikely the company completely disintegrated since then. But you wouldn't know it based on the SP. I've been caught in a tug-of-war between averaging down or not. On the one hand, I've had (mostly but not all) bad experiences doing this in the past. On the other hand, I have one major regret NOT averaging down and now see that one time as a tremendously missed opportunity.
I still think the "idea" of this company is a good, if not great one. But whether it can survive this desert nightmare is anybody's guess.
I do wish, though, FDSMF would change it's name and logo. The name Fandom is a boring cliche which brings up a million pages of search items. Without sports media on its end, fandom is meaningless.
Also, the brown girl with turquoise hair is an odd duck. Brown, blue-haired and dressed in pink, she looks drawn by a bored 8th grader with a middle class smirk stuck on her phony face. She should be furious and reaching to rip out your heart to eat it for lunch.
Agreed. HIVE had some hiccups as it went from less than a dollar to being accepted onto Nasdaq. It seems to have used its new legs to stand up well as it has shown a few quarters of noticebly growing profits and a positive balance sheet, unlike many of its competitors. HIVE used to sell bitcoins to fund itself instead of taking on debt. Now it's HODLing, as that is the current smarter financial growth model.
I think it takes about 6 or 8 quarters for the trend to appear stable to the big institutional investors. If HIVE stays on its feet for another 5 or 6 quarters, these could be years of more extraordinary growth. Of course, competition will keep HIVE on its toes. But it's recent growth has shown us that HIVE is capable of becoming a true ESG powerhouse which is aiming at a world audience, not just a North American one. HiVE seems to have proven itself capable of such responsible growth into the future.
Just jesting. Once all of the HALEU info is put on the table, then there will come a time of battle between forces supporting nuclear power as legit and those which see nuclear forces as not legit. The latter group sees this as religious dogma. This debate hasn't even yet begun. Will the green forces truly recognize nuclear as part of their club?
Perhap not a galactic battle, , but could be.
Right. Thanks for the reminder. I still think they're resting on laurals with their pants down. No movement, no statements and no plans for us to ponder. Does it mean they have no thoughts at all?
Will HIVE see an ethereum boost? If not, there is something fishy going on.
FDIC insurance would be world changing.
This group seems to have been caught with their pants down. I had thought more of Bitfury which is why I bought in. Perhaps they've been out of the game too long, resting on their laurels, forgetting how to play the real game of competition. Either they get their act together or they're gonna get sued. Can spacs be sued?
A toast to the SP catching up-- maybe surpassing--it's pre RS price. Didn't know I'd be back in the black in this decade.
I think we're about to watch a galactic battle between the progressive ideologs and the traditional dems. One side seems clearly out of their freaking minds. The other side, sometimes, seems not far behind. Not exactly a vote of confidence. But that's what makes galactic wars interesting, right?
Agree with that